Cargando…

919. Rates of False-Positive Hepatitis B Surface Antigen Is Low in Cancer Patients

BACKGROUND: Accurate interpretation of hepatitis B virus (HBV) laboratory testing is paramount in avoiding inaccurate diagnosis and incorrect management that could lead to unnecessary and overtreatment. This is particularly relevant in patients with cancer where universal testing is recommended in o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klingen, Joseph, Yibirin, Marcel, Hwang, Jessica P, Torres, Harrys A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643736/ http://dx.doi.org/10.1093/ofid/ofab466.1114

Ejemplares similares

1052. Serologic vs. molecular testing for screening for hepatitis C virus infection in patients with hematologic malignancies with and without prior hematopoietic cell transplant recipients
por: Torres, Harrys A, et al.
Publicado: (2020)

2197. Hepatitis B Reactivation in Patients with Malignancies Undergoing Treatment for Hepatitis C Infection with Direct-Acting Antivirals
por: Pritchard, Haley, et al.
Publicado: (2018)

919. Understanding Intermittent Detection of Multidrug-Resistant Organisms (MDROs) in Rectally Colonized Patients
por: Sansom, Sarah, et al.
Publicado: (2020)

1713. Impact of False-Positive Low-Titer Cryptococcal Antigen Testing
por: Bhatt, Mahesh, et al.
Publicado: (2019)

919 Rates of seroprevalance of COVID-19 among pregnant patients in New York City
por: Baptiste, Caitlin, et al.
Publicado: (2021)

1061. False Positive Human Immunodeficiency Virus Testing Due to Acute Hepatitis A Infection: A Case Series
por: Bandres, Maria V, et al.
Publicado: (2020)

P919: SIGNIFICANCE OF IHC AND BIOCHEMICAL MARKERS OF BONE METABOLISM FOR PREDICTING OSTEODESTRUCTIVE SYNDROME IN PLASMA CELL PROLIFERATION
por: Kozich, Z., et al.
Publicado: (2022)

2228. Late Viral Relapse After Direct-Acting Antiviral Treatment in Hepatitis C Virus-Infected Cancer Patients
por: Angelidakis, Georgios, et al.
Publicado: (2018)

Serologic versus molecular testing for screening for hepatitis C virus infection in patients with hematologic malignancies
por: Torres, Harrys A., et al.
Publicado: (2022)

2226. Immune Checkpoint Inhibitors in Solid Tumor Patients with Chronic Hepatitis C Virus Infection: A Prospective Case-Series
por: Hosry, Jeff, et al.
Publicado: (2018)

A Phase I study of NLG919 for adult patients with recurrent advanced solid tumors
por: Nayak, Asha, et al.
Publicado: (2014)

2227. Short-Duration of Direct-Acting Antivirals in Hepatitis C Virus-Infected Cancer Patients
por: Hosry, Jeff, et al.
Publicado: (2018)

2141. Potential for Harm From Rapid Campylobacter Antigen Test: Quality Improvement Process Reveals 84% False-Positive STAT! Campy Stool Antigen Results
por: Farrell, John J, et al.
Publicado: (2019)

Higher rates of false-positive HIV antigen/antibody screens during the COVID-19 pandemic: implications for pregnant patients
por: Miller, Madison E., et al.
Publicado: (2023)

Beam Disturbances during Run 919
por: Colchester, R J
Publicado: (1978)

Assessment of Fabry variant (IVS4+919G>A) Cardiomyopathy in Taiwanese: Emphasis on T1 mapping
por: Chang, Yu-pin, et al.
Publicado: (2016)

919. Let’s GO PO: Impact of Monthly Feedback on a Longitudinal Intravenous to Oral Antimicrobial Conversion Initiative
por: Hayes, Jillian E, et al.
Publicado: (2022)

The use of Direct-Acting Antivirals in Hepatitis C Virus-Infected Patients with Hepatocellular Carcinoma
por: Economides, Minas, et al.
Publicado: (2017)

288. Hepatitis B Virus Reactivation in Patients with Hematologic Malignancies after Anticancer Therapy Which Included Ibrutinib
por: Malek, Alexandre, et al.
Publicado: (2019)

An Interesting Case of Isolated False-Reactive Hepatitis B Surface Antigen
por: Costa, Victoria, et al.
Publicado: (2021)

258. False Negative Rate of T2Candida Assay in Blood Culture Positive Candidemia
por: McCarty, Todd, et al.
Publicado: (2019)

MRI assessment of cardiomyopathy in Taiwan Chinese late-onset Fabry mutation (IVS4+919G>A)
por: Chang, Yu-Pin, et al.
Publicado: (2015)

1066. Immune Escape Mutant Detection Using Commercially Available Methods for Hepatitis B Surface Antigen Serological Testing
por: Gish, Robert, et al.
Publicado: (2020)

Salvage Therapy in Cancer Patients With Hepatitis C Infection Failing Direct-Acting Antivirals: A Prospective Study
por: Pritchard, Haley, et al.
Publicado: (2017)

S164. “AT-RISK MENTAL STATES” PROGRAM IN LAUSANNE: INFLUENCE OF RECRUITMENT STRATEGIES ON THE RATE OF FALSE POSITIVES
por: Solida, Alessandra, et al.
Publicado: (2018)

1051. Rapid onset of seroprotection rates in young adults immunized with a tri-antigenic hepatitis B virus (HBV) vaccine compared to a mono-antigenic HBV vaccine
por: Vesikari, Timo, et al.
Publicado: (2020)

724. LDBIO Toxoplasma Test in the United States and Beyond: Review of the Device’s Performance on U.S. Samples and its Ability to Avoid False Positives
por: Grose, Andrew, et al.
Publicado: (2021)

919. Clinical and Microbiologic Characteristics Associated With Long-Term Orthopedic Complications Following Staphylococcus aureus Acute Hematogenous Osteoarticular Infections in Children
por: McNeil, J Chase, et al.
Publicado: (2018)

HYDEing the false positives – scoring for lead optimization
por: Schneider, N, et al.
Publicado: (2011)

919. Household Flu Transmission and Healthcare Resource Use among Patients Treated with Baloxavir versus Oseltamivir for Influenza: An Outpatient Prospective Survey in the United States
por: Best, Jennie H, et al.
Publicado: (2023)

919 Routine Hospital Acquired Infection surveys are feasible in low income health care settings and can inform quality improvement interventions
por: Ochola, Emmanuel, et al.
Publicado: (2014)

2031. False-positive Serologic Results attributable to IVIG therapy
por: Hanson, Kimberly E, et al.
Publicado: (2018)

P919: TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WITH ZOLEDRONIC ACID FOR FOUR YEARS INSTEAD OF TWO YEARS DECREASES RISK OF PROGRESSIVE BONE DISEASE WITHOUT INCREASING RISK OF OSTEONECROSIS OF THE JAW.
por: Gundesen, Michael, et al.
Publicado: (2023)

597. False Positive Carbapenemase Test in Carbapenem Resistant Acinetobacter baumannii
por: Tao, Lili, et al.
Publicado: (2023)

Direct-acting Antivirals Induce Lymphoproliferative Disease Response in HCV-infected Patients: A Prospective Case Series
por: Hosry, Jeff, et al.
Publicado: (2017)

PC43. Satisfaction with Breasts among Patients Undergoing Abdominal Free Flap Breast Reconstruction: Identification of Factors in 919 Patients
por: Kim, Minji, et al.
Publicado: (2023)

SP22. Satisfaction with Breasts among Patients Undergoing Abdominal Free Flap Breast Reconstruction: Identification of Factors in 919 Patients
por: Kim, Minji, et al.
Publicado: (2023)

Seroprevalence of Hepatitis B-surface antigen among selected group of population
por: Karim, Rezaul
Publicado: (2010)

1410. Isoniazid Therapy for Latent Tuberculosis Infection in Patients with Cancer Treated with Checkpoint Inhibitors Immunotherapy
por: Malek, Alexandre, et al.
Publicado: (2021)

BACH1 Ser919Pro variant and breast cancer risk
por: Vahteristo, Pia, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_j0l82fhpg3pcfqlf48tpa43tee